Skip to main content
Explore URMC

Kenneth Chin, M.D.

Contact Information

Phone Numbers

Appointment: (585) 341-6775

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentNot Accepting New Patients

Faculty Appointments

Patient Care Setting

Hospital Medicine


Dr. Chin was born and raised in Portland, Maine. He graduated magna cum laude from Northeastern University in Boston, Massachusetts where he studied biology and religious studies. After college he researched ovarian cancer at the Brigham and Women’s Hospital and Harvard Medical School. He went on to earn his medical degree from Tufts University School of Medicine. He completed his residency in Internal Medicine at the University of Rochester. He subsequently served a year as Chief Resident before joining the GAMA Internal Medicine Practice at Highland Hospital.

Dr. Chin’s passion is in General Internal Medicine and caring for patients both in the clinic as well as in the hospital. As a physician he views himself as a teacher with the goal of helping his patients better understand their conditions so they may be well informed and feel empowered to make a change in their health. His academic interests lie in Clinical Reasoning which is the study of the cognitive steps physicians make to arrive at a diagnosis and treatment plan.

While not practicing medicine Dr. Chin spends most of his time chasing his three children and working on his golf game in hopes of becoming a PGA Tour Professional one day.



MD | Tufts University School of Medicine

Post-doctoral Training & Residency

07/01/2016 - 06/25/2018
Residency in Internal Medicine at University of Rochester Medical Center

06/26/2015 - 06/30/2016
Internship in Internal Medicine at University of Rochester Medical Center


Journal Articles

Perets R, Wyant GA, Muto KW, Bijron JG, Poole BB, Chin KT, Chen JY, Ohman AW, Stepule CD, Kwak S, Karst AM, Hirsch MS, Setlur SR, Crum CP, Dinulescu DM, Drapkin R. "Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models." Cancer cell.. 2013 Dec 9; 24(6):751-65.

McAuliffe SM, Morgan SL, Wyant GA, Tran LT, Muto KW, Chen YS, Chin KT, Partridge JC, Poole BB, Cheng KH, Daggett J, Cullen K, Kantoff E, Hasselbatt K, Berkowitz J, Muto MG, Berkowitz RS, Aster JC, Matulonis UA, Dinulescu DM. "Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy." Proceedings of the National Academy of Sciences of the United States of America.. 2012 Oct 23; 109(43):E2939-48. Epub 2012 Sep 27.

Sengupta P, Basu S, Soni S, Pandey A, Roy B, Oh MS, Chin KT, Paraskar AS, Sarangi S, Connor Y, Sabbisetti VS, Kopparam J, Kulkarni A, Muto K, Amarasiriwardena C, Jayawardene I, Lupoli N, Dinulescu DM, Bonventre JV, Mashelkar RA, Sengupta S. "Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity." Proceedings of the National Academy of Sciences of the United States of America.. 2012 Jul 10; 109(28):11294-9. Epub 2012 Jun 25.